Ask AI
ProCE Banner Activity

Management of Neuropsychiatric Features in Alzheimer’s Disease Dementia

Slideset

This presentation will discuss how to recognize the psychiatric symptoms associated with dementia, the on-label and off-label medications and strategies used in Alzheimer’s disease psychosis, and dementia-related psychosis, and new and emerging treatments for treating neuropsychiatric symptoms in Alzheimer’s disease dementia.

Released: September 19, 2022

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Independent Educational Activity

Faculty Disclosure

Primary Author

Marwan Noel Sabbagh, MD, FAAN, FANA

Moreno Family Endowed Chair for Alzheimer’s Research
Director, Applied Alzheimer’s Research Laboratory
Professor of Neurology, Barrow Neurological Institute
Vice Chair for Clinical Research
Creighton University School of Medicine-Phoenix 
Phoenix, Arizona

Marwan Sabbagh, MD, FAAN: consultant/advisor/speaker: Alzheon, Biogen, Eisai, Genentech-Roche, KeifeRx, Lilly, NeuroTherapia, Novo Nordisk, Signant Health, Synaptogenix, T3D; ownership interest (stocks/stock options): Athira, Cortexyme/Quince Therapeutics, NeuroReserve, NeuroTau, Optimal Cognitive Health Company, Seq BioMarque, TransDermix, uMethod Health, Versanum; royalties or patent beneficiary: Humanix.